TrialJournal of acquired immune deficiency syndromes (1999)2013

No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana.

Sajini Souda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.